ABT-888, Carboplatin, and Paclitaxel for Cancer With Liver or Kidney Problems
- Status
- WITHDRAWN
- Phase
- PHASE1
Clinical Trials Related to Carboplatin
Related studies linked through entity extraction aliases.
Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Carboplatin and Paclitaxel With or Without Vorinostat in Treating Patients With Advanced Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck
- Status
- COMPLETED
- Phase
- PHASE2
Study of Pazopanib, Paclitaxel, and Carboplatin in Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Pazopanib Hydrochloride, Paclitaxel, and Carboplatin in Treating Patients With Refractory or Resistant Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Neoadjuvant Carboplatin, Eribulin and Trastuzumab for Operable HER2 Positive Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Carboplatin-based Chemotherapy With or Without Panitumumab in Platinum-sensitive Recurrent Ovarian Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
INOVATYON STUDY -International, Randomized Study in Patients With Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Cisplatin and Pemetrexed With Radiation Followed by Lobectomy
- Status
- TERMINATED
- Phase
- PHASE1
Carboplatin and Eribulin Mesylate in Triple Negative Breast Cancer Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Uterine Cancer
- Status
- TERMINATED
- Phase
- NA
Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer
- Status
- UNKNOWN
- Phase
- N/A
Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Study Evaluating the Safety and Efficacy of MEGF0444A in Combination With Carboplatin, Paclitaxel and Bevacizumab in Patients With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer Who Have Not Received Prior Chemotherapy for Advanced Disease (NILE)
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Bevacizumab Versus Placebo in Combination With Carboplatin/Paclitaxel in Participants With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer Who Have Not Received Previous Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Adavosertib (MK-1775) in Combination With Paclitaxel and Carboplatin Versus Paclitaxel and Carboplatin Alone for Participants With Platinum-Sensitive Ovarian Tumors With the P53 Gene Mutation (MK-1775-004)
- Status
- COMPLETED
- Phase
- PHASE2
Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1